Skip to content
Clinical Trials – home
Astrazeneca Farmaceutica Spain S.A.
Sponsor

Astrazeneca Farmaceutica Spain S.A.

Spain Calle Del Puerto De Somport 21-23, Poligono Industrial Carretera De Burgos, 28050 Madrid, Spain

About the sponsor

Research activity includes advanced or recurrent endometrial cancer, with interest in immunotherapy and targeted treatment approaches used in first-line disease management.

  • Endometrial cancer
  • Durvalumab
  • Olaparib

Clinical interest extends to pMMR disease and treatment settings involving platinum-based chemotherapy.

About Specializations

Astrazeneca Farmaceutica Spain S.A. runs clinical trials in conditions such as Mantle cell lymphoma, Small cell lung cancer, Endometrial cancer recurrent, Breast cancer, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

4 clinical trials

Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Acalabrutinib
  • Sponsor:Astrazeneca Farmaceutica Spain S.A.
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Durvalumab
  • Sponsor:Astrazeneca Farmaceutica Spain S.A.
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Durvalumab
  • Sponsor:Astrazeneca Farmaceutica Spain S.A.
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Capivasertib
  • Sponsor:Astrazeneca Farmaceutica Spain S.A.

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.